Update on the treatment of spinal cord injury

Progress in Brain Research

Volumn 161, Issue , 2007, Pages 217-233

  Baptiste, Darryl C ^a   Fehlings, Michael G ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

acute spinal cord injury; cell mediated repair; neuroprotection; pathobiology; pharmacologic therapy; rehabilitation

Indexed keywords

4 AMINOPYRIDINE; BA 210; CETHRIN; GANGLIOSIDE GM1; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MINOCYCLINE; NALOXONE; NERISPIRDINE; NEUROPROTECTIVE AGENT; NOGO 66 RECEPTOR; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN NOGO A; SODIUM CHANNEL BLOCKING AGENT; TIRILAZAD; UNCLASSIFIED DRUG;

BONE MARROW; CELL THERAPY; CLINICAL TRIAL; CONFUSION; DRUG DOSE COMPARISON; DRUG FATALITY; DRUG FORMULATION; DRUG MECHANISM; GAIT; HUMAN; LOADING DRUG DOSE; MACROPHAGE; NERVE CONDUCTION; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; OLFACTORY ENSHEATHING CELL; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; REHABILITATION CARE; RESTLESSNESS; REVIEW; SPINAL CORD DECOMPRESSION; SPINAL CORD INJURY; SPINAL CORD SURGERY; STEM CELL TRANSPLANTATION; STROMA CELL; TONIC CLONIC SEIZURE; TREADMILL EXERCISE; WOUND INFECTION;

ANIMALS; AXONS; CELL TRANSPLANTATION; HUMANS; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; SPINAL CORD INJURIES;

EID: 34347356392     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(06)61015-7     Document Type: Review

References (91)

1. AANS/CNS. Pharmacological therapy after acute cervical spinal cord injury. Neurosurgery 50 (2002) S63-S72
2. Agnati L.F., Fuxe K., Calza L., Benfenati F., Cavicchioli L., Toffano G., and Goldstein M. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. Acta Physiol. Scand. 119 (1983) 347-363
3. Bambakidis N.C., and Miller R.H. Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J. 4 (2004) 16-26
4. Baptiste D.C., Hartwick A.T., Jollimore C.A., Baldridge W.H., Seigel G.M., and Kelly M.E. An investigation of the neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death. Mol. Pharmacol. 66 (2004) 1113-1122
5. Baptiste D.C., Powell K.J., Jollimore C.A., Hamilton C., LeVatte T.L., Archibald M.L., Chauhan B.C., Robertson G.S., and Kelly M.E. Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Neuroscience 134 (2005) 575-582
6. Barnett S.C. Olfactory ensheathing cells: unique glial cell types?. J. Neurotrauma 21 (2004) 375-382
7. Bever Jr. C.T. The current status of studies of aminopyridines in patients with multiple sclerosis. Ann. Neurol. 36 Suppl (1994) S118-S121
8. Bomstein Y., Marder J.B., Vitner K., Smirnov I., Lisaey G., Butovsky O., Fulga V., and Yoles E. Features of skin-coincubated macrophages that promote recovery from spinal cord injury. J. Neuroimmunol. 142 (2003) 10-16
9. Bose B., Osterholm J.L., and Kalia M. Ganglioside-induced regeneration and reestablishment of axonal continuity in spinal cord-transected rats. Neurosci. Lett. 63 (1986) 165-169
10. Bracken M.B., Collins W.F., Freeman D.F., Shepard M.J., Wagner F.W., Silten R.M., Hellenbrand K.G., Ransohoff J., Hunt W.E., Perot Jr. P.L., et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251 (1984) 45-52
11. Bracken M.B., Shepard M.J., Collins Jr. W.F., Holford T.R., Baskin D.S., Eisenberg H.M., Flamm E., Leo-Summers L., Maroon J.C., Marshall L.F., et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second national acute spinal cord injury study. J. Neurosurg. 76 (1992) 23-31
12. Bracken M.B., Shepard M.J., Collins W.F., Holford T.R., Young W., Baskin D.S., Eisenberg H.M., Flamm E., Leo-Summers L., Maroon J., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second national acute spinal cord injury study. N. Engl. J. Med. 322 (1990) 1405-1411
13. Bracken M.B., Shepard M.J., Holford T.R., Leo-Summers L., Aldrich E.F., Fazl M., Fehlings M., Herr D.L., Hitchon P.W., Marshall L.F., Nockels R.P., Pascale V., Perot Jr. P.L., Piepmeier J., Sonntag V.K., Wagner F., Wilberger J.E., Winn H.R., and Young W. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third national acute spinal cord injury randomized controlled trial. National acute spinal cord injury study. JAMA 277 (1997) 1597-1604
14. Braughler J.M., and Hall E.D. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J. Neurosurg. 61 (1984) 290-295
15. Brundula V., Rewcastle N.B., Metz L.M., Bernard C.C., and Yong V.W. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125 (2002) 1297-1308
16. Cao Q., Benton R.L., and Whittemore S.R. Stem cell repair of central nervous system injury. J. Neurosci. Res. 68 (2002) 501-510
17. Caroni P., Savio T., and Schwab M.E. Central nervous system regeneration: oligodendrocytes and myelin as non-permissive substrates for neurite growth. Prog. Brain Res. 78 (1988) 363-370
18. Caroni P., and Schwab M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1 (1988) 85-96
19. Casha S., Yu W.R., and Fehlings M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103 (2001) 203-218
20. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., and Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403 (2000) 434-439
21. Cho K.O., La H.O., Cho Y.J., Sung K.W., and Kim S.Y. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. J. Neurosci. Res. 83 (2006) 285-291
22. Clark B.R., and Keating A. Biology of bone marrow stroma. Ann. N.Y. Acad. Sci. 770 (1995) 70-78
23. Coleman W.P., Benzel D., Cahill D.W., Ducker T., Geisler F., Green B., Gropper M.R., Goffin J., Madsen III P.W., Maiman D.J., Ondra S.L., Rosner M., Sasso R.C., Trost G.R., and Zeidman S. A critical appraisal of the reporting of the national acute spinal cord injury studies (II and III) of methylprednisolone in acute spinal cord injury. J. Spinal Disord. 13 (2000) 185-199
24. Cummings B.J., Uchida N., Tamaki S.J., Salazar D.L., Hooshmand M., Summers R., Gage F.H., and Anderson A.J. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci., U.S.A. 102 (2005) 14069-14074
25. DeForge D., Nymark J., Lemaire E., Gardner S., Hunt M., Martel L., Curran D., and Barbeau H. Effect of 4-aminopyridine on gait in ambulatory spinal cord injuries: a double-blind, placebo-controlled, crossover trial. Spinal Cord 42 (2004) 674-685
26. Delamarter R.B., Sherman J., and Carr J.B. Pathophysiology of spinal cord injury. Recovery after immediate and delayed decompression. J. Bone Joint Surg. Am. 77 (1995) 1042-1049
27. Dimitrijevic M.R., Gerasimenko Y., and Pinter M.M. Evidence for a spinal central pattern generator in humans. Ann. N.Y. Acad. Sci. 860 (1998) 360-376
28. Dobkin B., Apple D., Barbeau H., Basso M., Behrman A., DeForge D., Ditunno J., Dudley G., Elashoff R., Fugate L., Harkema S., Saulino M., and Scott M. Weight-supported treadmill vs. over-ground training for walking after acute incomplete SCI. Neurology 66 (2006) 484-493
29. Dobkin B.H., Curt A., and Guest J. Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil. Neural Repair 20 (2006) 5-13
30. Dommergues M.A., Plaisant F., Verney C., and Gressens P. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 121 (2003) 619-628
31. Doucette R. Olfactory ensheathing cells: potential for glial cell transplantation into areas of CNS injury. Histol. Histopathol. 10 (1995) 503-507
32. Dubreuil C.I., Winton M.J., and McKerracher L. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol. 162 (2003) 233-243
33. Duysens J., and Van de Crommert H.W. Neural control of locomotion: the central pattern generator from cats to humans. Gait Posture 7 (1998) 131-141
34. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., and Gage F.H. Neurogenesis in the adult human hippocampus. Nat. Med. 4 (1998) 1313-1317
35. Fass B., and Ramirez J.J. Effects of ganglioside treatments on lesion-induced behavioral impairments and sprouting in the CNS. J. Neurosci. Res. 12 (1984) 445-458
36. Fehlings M.G., and Perrin R.G. The timing of surgical intervention in the treatment of spinal cord injury: a systematic review of recent clinical evidence. Spine 31 (2006) S28-S36
37. Feron F., Perry C., Cochrane J., Licina P., Nowitzke A., Urquhart S., Geraghty T., and Mackay-Sim A. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 128 (2005) 2951-2960
38. Firouzi M., Moshayedi P., Saberi H., Mobasheri H., Abolhassani F., Jahanzad I., and Raza M. Transplantation of Schwann cells to subarachnoid space induces repair in contused rat spinal cord. Neurosci. Lett. 402 (2006) 66-70
39. Geisler F.H., Coleman W.P., Grieco G., and Poonian D. The Sygen multicenter acute spinal cord injury study. Spine 26 (2001) S87-S98
40. Geisler F.H., Dorsey F.C., and Coleman W.P. Recovery of motor function after spinal-cord injury - a randomized, placebo-controlled trial with GM-1 ganglioside. N. Engl. J. Med. 324 (1991) 1829-1838
41. Gruner J.A. A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 9 (1992) 123-128
42. Hall E.D., and Braughler J.M. Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue. Exp. Neurol. 73 (1981) 321-324
43. +-ATPase activity. Dose-response analysis during 1st hour after contusion injury in the cat. J. Neurosurg. 57 (1982) 247-253
44. Hansebout R.R., Blight A.R., Fawcett S., and Reddy K. 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients. J. Neurotrauma 10 (1993) 1-18
45. Hicks A.L., Adams M.M., Martin Ginis K., Giangregorio L., Latimer A., Phillips S.M., and McCartney N. Long-term body-weight-supported treadmill training and subsequent follow-up in persons with chronic SCI: effects on functional walking ability and measures of subjective well-being. Spinal Cord 43 (2005) 291-298
46. Hofstetter C.P., Schwarz E.J., Hess D., Widenfalk J., El Manira A., Prockop D.J., and Olson L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 2199-2204
47. Huang H., Chen L., Wang H., Xiu B., Li B., Wang R., Zhang J., Zhang F., Gu Z., Li Y., Song Y., Hao W., Pang S., and Sun J. Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin. Med. J. (Engl.) 116 (2003) 1488-1491
48. Hurlbert R.J. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J. Neurosurg. 93 (2000) 1-7
49. Hurlbert R.J. The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine 26 (2001) S39-S46
50. Johansson C.B., Momma S., Clarke D.L., Risling M., Lendahl U., and Frisen J. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96 (1999) 25-34
51. Johansson C.B., Svensson M., Wallstedt L., Janson A.M., and Frisen J. Neural stem cells in the adult human brain. Exp. Cell Res. 253 (1999) 733-736
52. Joshi M., and Fehlings M.G. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J. Neurotrauma 19 (2002) 175-190
53. Joshi M., and Fehlings M.G. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J. Neurotrauma 19 (2002) 191-203
54. Karimi-Abdolrezaee S., Eftekharpour E., Wang J., Morshead C.M., and Fehlings M.G. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J. Neurosci. 26 (2006) 3377-3389
55. Kernie S.G., Erwin T.M., and Parada L.F. Brain remodeling due to neuronal and astrocytic proliferation after controlled cortical injury in mice. J. Neurosci. Res. 66 (2001) 317-326
56. Knoller N., Auerbach G., Fulga V., Zelig G., Attias J., Bakimer R., Marder J.B., Yoles E., Belkin M., Schwartz M., and Hadani M. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J. Neurosurg. Spine 3 (2005) 173-181
57. Kohama I., Lankford K.L., Preiningerova J., White F.A., Vollmer T.L., and Kocsis J.D. Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J. Neurosci. 21 (2001) 944-950
58. Lee K.H., Yoon do H., Park Y.G., and Lee B.H. Effects of glial transplantation on functional recovery following acute spinal cord injury. J. Neurotrauma 22 (2005) 575-589
59. Li S., and Strittmatter S.M. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J. Neurosci. 23 (2003) 4219-4227
60. Li Y., Field P.M., and Raisman G. Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J. Neurosci. 18 (1998) 10514-10524
61. Lucas S.M., Rothwell N.J., and Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 Suppl 1 (2006) S232-S240
62. Man S.M., Ma Y.R., Shang D.S., Zhao W.D., Li B., Guo D.W., Fang W.G., Zhu L., and Chen Y.H. Peripheral T cells overexpress MIP-1 alpha to enhance its transendothelial migration in Alzheimer's disease. Neurobiol. Aging 28 (2007) 485-496
63. Miklossy J., Doudet D.D., Schwab C., Yu S., McGeer E.G., and McGeer P.L. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp. Neurol. 197 (2006) 275-283
64. Nashmi R., and Fehlings M.G. Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Res. Brain Res. Rev. 38 (2001) 165-191
65. Niederost B., Oertle T., Fritsche J., McKinney R.A., and Bandtlow C.E. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. 22 (2002) 10368-10376
66. Noorbakhsh F., Tsutsui S., Vergnolle N., Boven L.A., Shariat N., Vodjgani M., Warren K.G., Andrade-Gordon P., Hollenberg M.D., and Power C. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 203 (2006) 425-435
67. Oudega M., and Xu X.M. Schwann cell transplantation for repair of the adult spinal cord. J. Neurotrauma 23 (2006) 453-467
68. Park H.C., Shim Y.S., Ha Y., Yoon S.H., Park S.R., Choi B.H., and Park H.S. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng. 11 (2005) 913-922
69. Pellitteri R., Russo A., and Stanzani S. Schwann cell: a source of neurotrophic activity on cortical glutamatergic neurons in culture. Brain Res. 1069 (2006) 139-144
70. Pollard S.M., Conti L., Sun Y., Goffredo D., and Smith A. Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb. Cortex 16 (2006) i112-i120
71. Ramon-Cueto A., Cordero M.I., Santos-Benito F.F., and Avila J. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25 (2000) 425-435
72. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G.J., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M., Hadani M., and Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4 (1998) 814-821
73. Richardson P.M., McGuinness U.M., and Aguayo A.J. Axons from CNS neurons regenerate into PNS grafts. Nature 284 (1980) 264-265
74. Rivlin A.S., and Tator C.H. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg. Neurol. 10 (1978) 38-43
75. Savio T., and Schwab M.E. Rat CNS white matter, but not gray matter, is nonpermissive for neuronal cell adhesion and fiber outgrowth. J. Neurosci. 9 (1989) 1126-1133
76. Sekhon L.H., and Fehlings M.G. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26 (2001) S2-S12
77. Stirling D.P., Khodarahmi K., Liu J., McPhail L.T., McBride C.B., Steeves J.D., Ramer M.S., and Tetzlaff W. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci. 24 (2004) 2182-2190
78. Stokes B.T., Noyes D.H., and Behrmann D.L. An electromechanical spinal injury technique with dynamic sensitivity. J. Neurotrauma 9 (1992) 187-195
79. Stoy N., Mackay G.M., Forrest C.M., Christofides J., Egerton M., Stone T.W., and Darlington L.G. Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J. Neurochem. 93 (2005) 611-623
80. Syková E., Jendelova P., Urdzikova L., Lesny P., and Hejcl A. Bone marrow stem cells and polymer hydrogels: two strategies for spinal cord injury repair. Cell. Mol. Neurobiol. 26 (2006) 1111-1127
81. Tator C.H., Fehlings M.G., Thorpe K., and Taylor W. Current use and timing of spinal surgery for management of acute spinal cord injury in North America: results of a retrospective multicenter study. J. Neurosurg. 91 (1999) 12-18
82. Teng Y.D., Choi H., Onario R.C., Zhu S., Desilets F.C., Lan S., Woodard E.J., Snyder E.Y., Eichler M.E., and Friedlander R.M. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3071-3076
83. Tikka T.M., and Koistinaho J.E. Minocycline provides neuroprotection against N-methyl-d-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 166 (2001) 7527-7533
84. Van de Crommert H.W., Mulder T., and Duysens J. Neural control of locomotion: sensory control of the central pattern generator and its relation to treadmill training. Gait Posture 7 (1998) 251-263
85. Walmsley A.R., McCombie G., Neumann U., Marcellin D., Hillenbrand R., Mir A.K., and Frentzel S. Zinc metalloproteinase-mediated cleavage of the human Nogo-66 receptor. J. Cell Sci. 117 (2004) 4591-4602
86. Wells J.E., Hurlbert R.J., Fehlings M.G., and Yong V.W. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126 (2003) 1628-1637
87. Wiessner C., Bareyre F.M., Allegrini P.R., Mir A.K., Frentzel S., Zurini M., Schnell L., Oertle T., and Schwab M.E. Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J. Cereb. Blood Flow Metab. 23 (2003) 154-165
88. Winton M.J., Dubreuil C.I., Lasko D., Leclerc N., and McKerracher L. Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neurite outgrowth on inhibitory substrates. J. Biol. Chem. 277 (2002) 32820-32829
89. Xu L., Fagan S.C., Waller J.L., Edwards D., Borlongan C.V., Zheng J., Hill W.D., Feuerstein G., and Hess D.C. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol. 4 (2004) 7
90. Zheng M., and Kuffler D.P. Guidance of regenerating motor axons in vivo by gradients of diffusible peripheral nerve-derived factors. J. Neurobiol. 42 (2000) 212-219
91. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu du C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., and Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78